An AI-powered model may help identify premature infants at risk for PH and BPD using noninvasive eye pictures, a study has found.
United Therapeutics plans to seek FDA approval of ralinepag after a Phase 3 trial met its main goal in pulmonary arterial hypertension.
GSK is acquiring 35Pharma for $950 million, and getting rights to HS235, a potential best-in-class PH treatment now in early clinical testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results